Clinical Trial Update: Efficacy and Safety of Low-Dose Colchicine on Surrogate Markers of Cardiovascular Events in People Living With HIV Receiving Antiretroviral Therapy [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating low-dose colchicine for efficacy and safety on surrogate cardiovascular markers in people living with HIV on antiretroviral therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Mahidol University | Conditions: HIV Infections, Inflammatory Markers | Phase 4 | Status: UNKNOWN